Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
Clinical trial NCT06083675 · WITHDRAWN
Trial details
- NCT number
- NCT06083675
- Sponsor
- Novo Nordisk A/S
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-26
- Primary completion
- 2025-01-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.